Swot Analysis

1127 WordsMay 5, 20155 Pages
Allergen SWOT Analysis Name Institution Allergen SWOT Analysis Founded in 1950, Allergen is among the most powerful and effective pharmaceutical companies in United States of America. It is a multi-specialty corporation that has been developing, commercializing and discovering the groundbreaking pharmaceuticals, medical devices etc. The company is best known for its products for neurological disorders, breast cure, obesity control, skin problems, ophthalmological disorders and many more specialty marketplace. Data clearly states that over the sale (OTC) as well as sales of medicament of the pharmaceutical business is worth $650 billion annually. In this oversize pharmaceutical revenue, Allergen has been among the most effective…show more content…
The most reasonable weakness connected with high reliance on Botox sales is the threat of concentration. In any business Concentration risk increases with this high dependency on single product. Other weakness is the entrenchment in little growing therapy parts like CNS and CV. This fortification can be very dangerous in the long run. The company has got this internal weakness. Along with that, the company has very inadequate infiltration of biologics arcade. The most obvious weakness of Allergen is the cessation of any type of product at its advanced phases of development. Critics have pointed out this internal weakness for years. The company discontinues any further progress on a product when the product is in its final stages. Majority of company’s revenue comes from United States. Company should consider this weakness. The market is too rich outside the United States. Allergen is not working effectively in developing markets like china, India, Turkey etc. They are developing economies and the company should consider new emerging markets. Most commonly known as M&A action, the currents in epic promotions from 1999 to 2004 have revealed much weaknesses of the business. In addition to this, the co-marketing settlements can restrict Pfizer’s international existence. This weakness can cause much damage in future. Opportunities The opportunities for pharmaceutical companies have been there. New marketplaces

More about Swot Analysis

Open Document